Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -21.57x is 96% above its 5-year average of -484.60x, near the high end of its 5-year range (-1447.06x–4.10x).
26.05% below its 12-month average of -17.11x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -38.33x.
INTEREST COVERAGE RATIO
-21.57x
INTEREST COVERAGE RATIO AVG TTM
-17.11x
INTEREST COVERAGE RATIO AVG 3Y
-317.02x
INTEREST COVERAGE RATIO AVG 5Y
-484.60x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.05%
CURRENT VS 3Y AVG
+93.20%
CURRENT VS 5Y AVG
+95.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-238.35%
vs the sector median at left
Cingulate Inc.
Market Cap
$67.01M
Interest Coverage Ratio
-21.57x
TTM Avg
-17.11x
3Y Avg
-317.02x
5Y Avg
-484.60x
Market Cap
$68.08M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.85M
Interest Coverage Ratio
-632.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.71M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.04M
Interest Coverage Ratio
-1174.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.83M
Interest Coverage Ratio
-14.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.19M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.56M
Interest Coverage Ratio
-66.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $67.01M | -21.57x | -17.11x | -317.02x | -484.60x |
| iBio, Inc. (IBIO)vs › | $66.82M | -663.04x | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | -632.78x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.71M | -8.06x | N/A | N/A | N/A |
| Tiziana Life Sciences Ltd (TLSA)vs › | $69.04M | -1174.00x | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | -14.86x | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.56M | -66.90x | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $63.52M | N/A | N/A | N/A | N/A |
Interest Coverage
-21.6x
Debt/Equity
0.27
Current Ratio
3.50
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -38.33x |
| 2025-12-31 | 4.10x |
| 2024-06-30 | -916.84x |
| 2023-03-31 | -24.86x |
| 2021-09-30 | -1447.06x |
| 2020-12-31 | -28.40x |
| 2020-09-30 | -24.80x |
| 2020-06-30 | -313.47x |
| 2020-03-31 | -313.47x |
